Kura Oncology KURA
NASDAQ KURA
$10.65 -0.06 (-0.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Convertible Debt (2014)

Updated

Kura Oncology's Convertible Debt was $500,000 in Q4 2014.

Analysis

Kura Oncology (KURA) Convertible Debt (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 500,000.00
API Access

Kura Oncology Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=KURA&period=max&api_key=YOUR_API_KEY